Published in Pediatrics on April 02, 2012
Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study. CMAJ (2014) 1.00
Recent Research on Febrile Seizures: A Review. J Neurol Neurophysiol (2013) 0.79
Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012. J Prev Med Hyg (2014) 0.75
Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China. PLoS One (2017) 0.75
Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012. Vaccines (Basel) (2013) 0.75
Combination measles-mumps-rubella-varicella vaccination and the risk of febrile seizure. CMAJ (2014) 0.75
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Influenza-associated hospitalizations in the United States. JAMA (2004) 18.23
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2011) 14.93
The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine (2007) 9.96
Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med (2010) 7.37
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis (2007) 5.91
Unintended consequences of caps on Medicare drug benefits. N Engl J Med (2006) 5.67
Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA (2003) 4.56
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med (2007) 4.16
Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med (2010) 3.83
Use of e-Health services between 1999 and 2002: a growing digital divide. J Am Med Inform Assoc (2004) 3.56
Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med (2003) 3.49
Azithromycin for the secondary prevention of coronary events. N Engl J Med (2005) 3.42
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA (2013) 3.30
Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet (2008) 3.23
Maternal and paternal age and risk of autism spectrum disorders. Arch Pediatr Adolesc Med (2007) 3.22
Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med (2012) 3.12
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis (2013) 3.00
The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis (2004) 2.96
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J (2002) 2.94
Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med (2002) 2.90
Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr (2013) 2.86
Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Viruses (2009) 2.82
Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis (2005) 2.74
Validation of an algorithm for categorizing the severity of hospital emergency department visits. Med Care (2010) 2.67
Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis (2002) 2.64
Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA (2002) 2.58
Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 years. Vaccine (2012) 2.43
Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics (2010) 2.39
Statin exposure is associated with decreased asthma-related emergency department visits and oral corticosteroid use. Am J Respir Crit Care Med (2013) 2.36
Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis (2007) 2.34
Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs. JAMA (2008) 2.31
Influenza- and RSV-associated hospitalizations among adults. Vaccine (2006) 2.23
Comorbid depression, chronic pain, and disability in primary care. Psychosom Med (2006) 2.20
National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. Ann Intern Med (2009) 2.19
Coinfections acquired from ixodes ticks. Clin Microbiol Rev (2006) 2.11
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J (2006) 2.10
Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season. J Infect Dis (2013) 2.07
Meaningful variation in performance: what does variation in quality tell us about improving quality? Med Care (2010) 2.05
Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. MMWR Morb Mortal Wkly Rep (2015) 2.01
Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Arch Intern Med (2007) 2.00
Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2010) 1.99
Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics (2008) 1.96
Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis (2006) 1.96
Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One (2011) 1.94
National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend (2013) 1.91
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J (2004) 1.90
Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J (2003) 1.86
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI). Vaccine (2009) 1.85
The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators. BMJ (2010) 1.85
Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav (2005) 1.84
Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care (2009) 1.79
Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2012) 1.78
Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med (2006) 1.75
Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology (2009) 1.74
Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine (2008) 1.74
Estimating influenza-associated deaths in the United States. Am J Public Health (2009) 1.73
New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol (2009) 1.72
Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine (2009) 1.71
Reduction in antibiotic use among US children, 1996-2000. Pediatrics (2003) 1.71
Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine (2011) 1.70
Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection. Blood (2012) 1.68
Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J (2004) 1.68
Real-time vaccine safety surveillance for the early detection of adverse events. Med Care (2007) 1.66
Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics (2008) 1.63
The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics (2011) 1.60